These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25230994)

  • 1. Is "option B+" also being adopted in pregnant women in high-income countries? Temporal trends from a national study in Italy.
    Floridia M; Guaraldi G; Ravizza M; Tibaldi C; Pinnetti C; Maccabruni A; Molinari A; Liuzzi G; Alberico S; Meloni A; Rizzi L; Dalzero S; Tamburrini E;
    Clin Infect Dis; 2015 Jan; 60(1):159-61. PubMed ID: 25230994
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS.
    Coovadia H
    N Engl J Med; 2004 Jul; 351(3):289-92. PubMed ID: 15247337
    [No Abstract]   [Full Text] [Related]  

  • 3. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
    Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late pregnancy screening for human immunodeficiency virus.
    Steele RW
    Pediatr Infect Dis J; 2011 Jan; 30(1):72-4. PubMed ID: 20686432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of low birthweight infants in HIV-infected women delivered in Rajavithi Hospital.
    Asavapiriyanont S; Kasiwat S
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S66-70. PubMed ID: 21717881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protecting the next generation--eliminating perinatal HIV-1 infection.
    Mofenson LM
    N Engl J Med; 2010 Jun; 362(24):2316-8. PubMed ID: 20554987
    [No Abstract]   [Full Text] [Related]  

  • 7. National guidelines for the management of HIV-1 in pregnancy.
    Lyons F; Butler K; Coulter Smith S; Mulcahy F
    Ir Med J; 2006 May; 99(5):152-4. PubMed ID: 16892923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cohort profile: the Swiss HIV Cohort study.
    ; Schoeni-Affolter F; Ledergerber B; Rickenbach M; Rudin C; Günthard HF; Telenti A; Furrer H; Yerly S; Francioli P
    Int J Epidemiol; 2010 Oct; 39(5):1179-89. PubMed ID: 19948780
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapy in pregnant women of Florence.
    Trotta M; Meli M; Ginelli R; Sbaragli S; Leoncini F
    Int J Infect Dis; 2001; 5(4):230-1. PubMed ID: 11953225
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiretroviral pharmacology: special issues regarding pregnant women and neonates.
    Mirochnick M; Best BM; Clarke DF
    Clin Perinatol; 2010 Dec; 37(4):907-27, xi. PubMed ID: 21078458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Option B+ for prevention of mother-to-child transmission of HIV in resource-constrained settings: great promise but some early caution.
    Shaffer N; Abrams EJ; Becquet R
    AIDS; 2014 Feb; 28(4):599-601. PubMed ID: 24469000
    [No Abstract]   [Full Text] [Related]  

  • 13. Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention.
    Toro PL; Katyal M; Carter RJ; Myer L; El-Sadr WM; Nash D; Abrams EJ;
    AIDS; 2010 Feb; 24(4):515-24. PubMed ID: 19996939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from the 11th conference on retroviruses and opportunistic infections.
    Laurence J
    AIDS Read; 2004 Apr; 14(4):151-3. PubMed ID: 15116693
    [No Abstract]   [Full Text] [Related]  

  • 15. The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?
    Martin F; Taylor GP
    J Antimicrob Chemother; 2009 Nov; 64(5):895-900. PubMed ID: 19706669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy in the developing world.
    Chulamokha L; DeSimone JA; Pomerantz RJ
    J Neurovirol; 2005; 11 Suppl 1():76-80. PubMed ID: 15960241
    [No Abstract]   [Full Text] [Related]  

  • 18. Pregnancy outcomes and antiretroviral treatment in a national cohort of pregnant women with HIV: overall rates and differences according to nationality.
    Floridia M; Tamburrini E; Bucceri A; Tibaldi C; Anzidei G; Guaraldi G; Meloni A; Guerra B; Ferrazzi E; Molinari A; Pinnetti C; Salerio B; Ravizza M;
    BJOG; 2007 Jul; 114(7):896-900. PubMed ID: 17501959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus and pregnancy.
    Reshi P; Lone IM
    Arch Gynecol Obstet; 2010 May; 281(5):781-92. PubMed ID: 20035338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of fosamprenavir in human immunodeficiency virus-infected pregnant women.
    Martorell C; Theroux E; Bermudez A; Garb J; Kronschnabel D; Oie K
    Pediatr Infect Dis J; 2010 Oct; 29(10):985. PubMed ID: 20859183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.